STVN dividend history

Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announced today that the resolution proposed to shareholders at the Extraordinary General Meeting of Shareholders ("EGM") held virtually on October 4, 2023 was passed. Details of the resolution submitted to, and approved by, the EGM are included in the explanatory report prepared by the Board of Directors of the Company, which is available on the Company's corporate website at https://ir.stevanatogroup.com/shareholders-meetings. The Shareholders resolved to delegate to the Board of Directors of the Com

Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it has changed the previously announced ex-dividend date of June 5, 2023 for its cash dividend of EUR 0.054 per share, payable on July 17, 2023, to comply with New York Stock Exchange rules. The new ex-dividend date for the dividend will be June 7, 2023, and the record date remains June 6, 2023. The dividend will continue to be payable on July 17, 2023. About Stevanato Group Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diag

Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announced today that all resolutions proposed to Shareholders at the Annual General Meeting of Shareholders ("AGM") held virtually on June 1, 2022 were passed. Details of the resolutions submitted to, and approved by, the AGM are included in the explanatory report prepared by the board of directors of the Company, which is available on the Company's corporate website at https://ir.stevanatogroup.com/. In the ordinary part of the AGM the Shareholders approved, among other things, the annual financial stat